<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28492788</article-id><article-id pub-id-type="pmc">5409247</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2016-0010</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Hemoglobin A<sub>1c</sub> Levels Predicts Acute Kidney Injury after
Coronary Artery Bypass Surgery in Non-Diabetic Patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kocogullar&#x00131;</surname><given-names>Cevdet Ugur</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kunt</surname><given-names>Atike Tekeli</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Aksoy</surname><given-names>Rezan</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Duzyol</surname><given-names>Cagr&#x00131;</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Parlar</surname><given-names>Hakan</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Sask&#x00131;n</surname><given-names>Huseyin</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>F&#x00131;nd&#x00131;k</surname><given-names>Orhan</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Siyami Ersek Training and Research Hospital, Istanbul, Turkey.</aff><aff id="aff2"><label>2</label>Derince Training and Research Hospital, Kocaeli, Turkey.</aff><aff id="aff3"><label>3</label>Kartal Kosuyolu Training and Research Hospital, Istanbul,
Turkey.</aff><author-notes><corresp id="c1">Correspondence Address: Rezan Aksoy, Cevizli Mah., Denizer Cad.
Cevizli Kav&#x0015f;a&#x0011f;&#x00131;, Istanbul, Turkey - Zip code: 34865.
E-mail: <email>rezanaksoy@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Mar-Apr</season><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2017</year></pub-date><volume>32</volume><issue>2</issue><fpage>83</fpage><lpage>89</lpage><history><date date-type="received"><day>02</day><month>9</month><year>2016</year></date><date date-type="accepted"><day>06</day><month>12</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p> Elevated hemoglobin A<sub>1c</sub> levels in patients with diabetes mellitus
have been known as a risk factor for acute kidney injury after coronary
artery bypass grafting. However, the relationship between hemoglobin
A<sub>1c</sub> levels in non-diabetics and acute kidney injury is under
debate. We aimed to investigate the association of preoperative hemoglobin
A<sub>1c</sub> levels with acute kidney injury in non-diabetic patients
undergoing isolated coronary artery bypass grafting.</p></sec><sec><title>Methods</title><p>202 non-diabetic patients with normal renal function (serum creatinine
&#x0003c;1.4 mg/dl) who underwent isolated coronary bypass were analyzed.
Hemoglobin A<sub>1c</sub> level was measured at the baseline examination.
Patients were separated into two groups according to preoperative Hemoglobin
A<sub>1c</sub> level. Group 1 consisted of patients with preoperative
HbA<sub>1c</sub> levels of &#x0003c; 5.6% and Group 2 consisted of patients
with preoperative HbA<sub>1c</sub> levels of &#x02265; 5.6%. Acute kidney
injury diagnosis was made by comparing baseline and postoperative serum
creatinine to determine the presence of predefined significant change based
on the Kidney Disease Improving Global Outcomes (KDIGO) definition.</p></sec><sec><title>Results</title><p>Acute kidney injury occurred in 19 (10.5%) patients after surgery. The
incidence of acute kidney injury was 3.6% in Group 1 and 16.7% in Group 2.
Elevated baseline hemoglobin A<sub>1c</sub> level was found to be associated
with acute kidney injury (<italic>P</italic>=0.0001). None of the patients
became hemodialysis dependent. The cut off value for acute kidney injury in
our group of patients was 5.75%.</p></sec><sec><title>Conclusion</title><p>Our findings suggest that, in non-diabetics, elevated preoperative hemoglobin
A<sub>1c</sub> level may be associated with acute kidney injury in
patients undergoing coronary artery bypass grafting. Prospective randomized
studies in larger groups are needed to confirm these results.</p></sec></abstract><kwd-group><kwd>Coronary Artery Bypass</kwd><kwd>Kidney</kwd><kwd>Dialysis</kwd><kwd>Acute Kidney Injury</kwd><kwd>Mammary Arteries</kwd></kwd-group></article-meta></front><body><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="20%" span="1"/><col width="80%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ACT</td><td align="left" rowspan="1" colspan="1">= Activated clotting time</td></tr><tr><td align="left" rowspan="1" colspan="1">AKI</td><td align="left" rowspan="1" colspan="1">= Acute kidney injury</td></tr><tr><td align="left" rowspan="1" colspan="1">AUC</td><td align="left" rowspan="1" colspan="1">= Area under curve</td></tr><tr><td align="left" rowspan="1" colspan="1">BUN</td><td align="left" rowspan="1" colspan="1">= Blood urea nitrogen</td></tr><tr><td align="left" rowspan="1" colspan="1">CABG</td><td align="left" rowspan="1" colspan="1">= Coronary artery bypass grafting</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB</td><td align="left" rowspan="1" colspan="1">= Cardiopulmonary bypass</td></tr><tr><td align="left" rowspan="1" colspan="1">DM</td><td align="left" rowspan="1" colspan="1">= Diabetes mellitus</td></tr><tr><td align="left" rowspan="1" colspan="1">GFR</td><td align="left" rowspan="1" colspan="1">= Glomerular filtration rate</td></tr><tr><td align="left" rowspan="1" colspan="1">HbA1c</td><td align="left" rowspan="1" colspan="1">= Hemoglobin A1c</td></tr><tr><td align="left" rowspan="1" colspan="1">ICU</td><td align="left" rowspan="1" colspan="1">= Intensive care unit</td></tr><tr><td align="left" rowspan="1" colspan="1">KDIGO</td><td align="left" rowspan="1" colspan="1">= Kidney Disease Improving Global Outcomes</td></tr><tr><td align="left" rowspan="1" colspan="1">LAD</td><td align="left" rowspan="1" colspan="1">= Left anterior descending artery</td></tr><tr><td align="left" rowspan="1" colspan="1">LIMA</td><td align="left" rowspan="1" colspan="1">= Left internal mammary artery</td></tr><tr><td align="left" rowspan="1" colspan="1">LVEF</td><td align="left" rowspan="1" colspan="1">= Left ventricular ejection fraction</td></tr><tr><td align="left" rowspan="1" colspan="1">ROC</td><td align="left" rowspan="1" colspan="1">= Receiver operating characteristic</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Coronary artery bypass grafting (CABG) operations are performed safely and
successfully in our country as well as in the rest of the world. Acute kidney injury
(AKI), not rarely seen following cardiac surgery, is associated with morbidity,
increased health costs, and mortality rates<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>The risk factors and pathophysiology of AKI following CABG were described in the
literature and have been the subject of multiple studies<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>]</sup>.</p><p>The incidence of AKI following cardiac surgery has been reported as being 5-30% and
renal replacement therapy is required in 1-2% of these patients<sup>[<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref>]</sup>. Hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>) is widely
used as a marker of average blood glucose concentrations over the preceding 2 to 3
months and it has advantages over glucose tests<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. Some evidence indicates that high
HbA<sub>1c</sub> levels prior to surgery are strongly associated with the
severity of adverse events after CABG<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>.</p><p>HbA<sub>1c</sub> levels were found to be related to cardiovascular and renal
complications following open heart surgery<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. Multiple factors have been implicated as
contributors to postoperative AKI, including advanced age, female gender, presence
of diabetes mellitus, chronic kidney disease, extended time between heart
catheterization and surgery, aortic cross clamp time, duration of cardiopulmonary
bypass (CPB), and blood transfusion following surgery<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>.</p><p>However, association of elevated HbA<sub>1c</sub>levels in non-diabetics with AKI
after CABG surgery is under debate. The purpose of this study is to investigate the
association of preoperative HbA<sub>1c</sub> levels in non-diabetics with AKI after
isolated CABG.</p></sec><sec sec-type="methods"><title>METHODS</title><p>In this study, medical records of 315 open cardiac surgery patients operated in the
same center by the same surgical team between June 2012 and July 2014 were
investigated consecutively and retrospectively. Patients who underwent isolated CABG
with CPB and who were non-diabetic with preoperative serum creatinine levels less
than 1.4 mg/dl were included in the study. The number of patients that met that
criteria was 202. For descriptive purposes, receiver operating characteristic (ROC)
curve analysis was performed to identify the cut-off point with the highest
sensitivity and specificity. Patients were grouped according to HbA<sub>1c</sub>
status: &#x0003c; 5.6% (low HbA<sub>1c</sub> group; group 1) and &#x02265;5.6% (high
HbA<sub>1c</sub> group; group 2).</p><p>AKI diagnosis was made by comparing baseline and postoperative serum creatinine to
determine the presence of predefined significant change based on the Kidney Disease
Improving Global Outcomes (KDIGO) definition (increase in serum creatinine by
&#x02265;0.3 mg/dl within 48 hours of surgery or increase in serum creatinine to
&#x02265;1.5 times baseline within 3 days of cardiac surgery)<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. AKI diagnosis was based
on the highest serum creatinine concentration measured during the first 3 days after
surgery compared to the baseline serum creatinine concentration, defined as the last
concentration measured before surgery. Urine output was not used to define AKI
because it may be influenced by diuretics administered during anesthesia and
CPB.</p><p>Exclusion criteria included patients who had peripheral arterial disease, moderate to
severe valvular heart disease, decompensated congestive heart failure, congenital
cardiac disease, cerebrovascular event in the last 30 days, malignancy,
endocrinological disorders (hypothyroidism, hyperthyroidism), low hemoglobin levels
(&#x02264;10 g/dl), acute infections, emergency operations; patients who had previous
diagnosis of end-stage renal disease and who were on dialysis; patients who were
reoperated due to hemodynamic instability or bleeding; patients who required
intra-aortic balloon pump; patients who had acute myocardial infarction and
percutaneous coronary intervention in the last 30 days prior to operation; and
patients who were operated on beating heart or redo CABG. A total of 113 patients
were excluded from study, as shown in <xref ref-type="fig" rid="f1">Figure 1</xref>.
Additionally, patients for whom data on serum creatinine levels or urine output were
missing were also excluded.</p><p><fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Consort diagram figure of patient selection.</p></caption><graphic xlink:href="rbccv-32-02-0083-g01"/></fig></p><p>Patients' demographic and clinical data were obtained by using the hospital's
software system of records and archives to investigate patient files, epicrisis,
operation notes, and laboratory results. Age, gender, smoking history, hypertension,
hyperlipidemia, left ventricular ejection fraction (LVEF), preoperative and
postoperative laboratory parameters (hemoglobin, fasting blood glucose, creatinine,
urea, creatinine clearance), perioperative data, duration of CPB and aortic cross
clamp, amount of blood products used, and intensive care unit (ICU) and hospital
length of stay were recorded.</p><p>Patients were followed in the ICU in the postoperative period, according to protocols
of our institution. Electrocardiography, systemic mean arterial pressure, central
venous pressure, arterial blood gases, chest tube drainage, and urine output were
monitored. Preoperative and postoperative creatinine clearances and peak creatinine
clearance were calculated according to the formulas reported in the
literature<sup>[<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref>]</sup>.</p><sec><title>Operative Technique</title><p>All of the patients were operated with median sternotomy under general anesthesia
and CPB with aortic and venous cannulations following systemic heparin
administration (300 IU/kg). Activated clotting time (ACT) was maintained at over
450 seconds during the operation. Standard CPB circuit and surgical management
were used. Antegrade hypothermic and hyperkalemic blood cardioplegia was applied
to all patients. Surgery was performed under moderate systemic hypothermia
(28-30&#x000ba;C). CPB flow was maintained at 2.2-2.5 l/min/m<sup>2</sup>, mean
perfusion pressure was maintained between 50 and 80 mmHg, hematocrit level was
maintained between 20 to 25% during CPB. For the coronary bypass operations,
arterial grafts for left anterior descending artery (LAD) revascularization were
preferably harvested from the left internal mammary artery (LIMA) whereas
saphenous venous grafts were used for the other vessels. Distal anastomoses were
done during aortic cross-clamp period and proximal anastomoses were done on
beating heart onto the ascending aorta using a lateral clamp.</p></sec><sec><title>Statistical Analysis</title><p>Statistical analysis was performed using SPSS version 13.0 (SPSS Inc, Chicago,
IL, USA). Normal distribution was evaluated by histogram or Kolmogorov-Smirnov
test; homogeneity of distribution was evaluated by 'Levene's test for equality
of variance'. Normally distributed data were demonstrated as mean &#x000b1;
standard deviation whereas non-normally distributed data were demonstrated as
median (minimum-maximum). Difference between groups was evaluated by 'Student's
t test' in normal and homogenous distribution and by 'Mann-Whitney U test' in
non-normal distribution. Differences between groups were evaluated by parametric
or non-parametric Pearson Chi-Square test or Fisher's Exact test with respect to
the distribution. Forward stepwise multivariate logistic regression models were
created to identify the independent predictors of postoperative AKI. Variables
with a <italic>P</italic> value less than 0.10 in univariate analyses were
included in the multivariate model. The sensitivity and specificity of the
independent risk factors to predict postoperative AKI were determined by ROC
curve analysis. <italic>P</italic> value less than 0.05 was accepted as
significant. Chi-square test was performed for odds ratio. Continuous variables
were described as means (standard deviation) or medians (interquartile range),
as appropriate; categorical variables were described as percentage.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>The demographic characteristics and clinical data of the patients were summarized in
<xref ref-type="table" rid="t1">Table 1</xref>. There were no differences
between the two groups in terms of demographic or clinical data.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Demographic and clinical properties of the patients.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="center" rowspan="2" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">HbA<sub>1c</sub> &#x0003c;5.6</th><th align="center" rowspan="1" colspan="1">HbA<sub>1c</sub> &#x02265;5.6</th><th align="center" rowspan="2" colspan="1"><italic>P</italic> value</th></tr><tr><th align="center" rowspan="1" colspan="1">Group 1 (n=112)</th><th align="center" rowspan="1" colspan="1">Group 2 (n=90)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, years Median (min-max)</td><td align="center" rowspan="1" colspan="1">63 (36-82)</td><td align="center" rowspan="1" colspan="1">60 (33-82)</td><td align="center" rowspan="1" colspan="1">0.47<xref ref-type="table-fn" rid="TFN2">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Male (%)</td><td align="center" rowspan="1" colspan="1">88 (78.6%)</td><td align="center" rowspan="1" colspan="1">74 (82.2%)</td><td align="center" rowspan="1" colspan="1">0.52<xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Female (%)</td><td align="center" rowspan="1" colspan="1">24 (21.4%)</td><td align="center" rowspan="1" colspan="1">16 (17.8%)</td><td align="center" rowspan="1" colspan="1">0.52<xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension (%)</td><td align="center" rowspan="1" colspan="1">73 (65.2%)</td><td align="center" rowspan="1" colspan="1">51 (56.7%)</td><td align="center" rowspan="1" colspan="1">0.22<xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Hyperlipidemia (%)</td><td align="center" rowspan="1" colspan="1">50 (44.6%)</td><td align="center" rowspan="1" colspan="1">45 (50.0%)</td><td align="center" rowspan="1" colspan="1">0.45<xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking (%)</td><td align="center" rowspan="1" colspan="1">51 (45.5%)</td><td align="center" rowspan="1" colspan="1">33 (36.7%)</td><td align="center" rowspan="1" colspan="1">0.20<xref ref-type="table-fn" rid="TFN1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Ejection fraction Median (min-max)</td><td align="center" rowspan="1" colspan="1">58 (25-70)</td><td align="center" rowspan="1" colspan="1">58 (30-70)</td><td align="center" rowspan="1" colspan="1">0.42<xref ref-type="table-fn" rid="TFN2">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">EuroSCORE Median (min-max)</td><td align="center" rowspan="1" colspan="1">2 (0-6)</td><td align="center" rowspan="1" colspan="1">1 (0-6)</td><td align="center" rowspan="1" colspan="1">0.19<xref ref-type="table-fn" rid="TFN2">**</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p>Pearson Chi-Square test or Fisher's Exact test;</p></fn><fn id="TFN2"><label>**</label><p>Mann-Whitney U test</p></fn></table-wrap-foot></table-wrap><p>Preoperative and postoperative blood analysis and haematological parameters of the
patients were summarized in <xref ref-type="table" rid="t2">Table 2</xref>. First
postoperative day creatinine levels (<italic>P</italic>=0.01), 3<sup>rd</sup>
postoperative day creatinine levels (<italic>P</italic>=0.0001), and 7<sup>th</sup>
postoperative day creatinine levels (<italic>P</italic>=0.0001) were significantly
different between the groups.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Preoperative and early postoperative blood results and haematological
parameters of patient.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Preoperative and early postoperative blood
results and haematological parameters</th><th align="center" rowspan="1" colspan="1">HbA<sub>1c</sub> &#x0003c;5.6 Group 1 (n=112)</th><th align="center" rowspan="1" colspan="1">HbA<sub>1c</sub> &#x02265;5.6 Group 2 (n=90)</th><th align="center" rowspan="2" colspan="1"><italic>P</italic> value</th></tr><tr><th align="center" rowspan="1" colspan="1">Median (min-max)</th><th align="center" rowspan="1" colspan="1">Median (min-max)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Preoperative haemoglobin (mg/dl)</td><td align="center" rowspan="1" colspan="1">13.6 (10.4-16.5)</td><td align="center" rowspan="1" colspan="1">13.8 (10.5-16.0)</td><td align="center" rowspan="1" colspan="1">0.39<xref ref-type="table-fn" rid="TFN5">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative creatinine (mg/dl)</td><td align="center" rowspan="1" colspan="1">0.90 (0.60-1.38)</td><td align="center" rowspan="1" colspan="1">0.90 (0.60-1.30)</td><td align="center" rowspan="1" colspan="1">0.32<xref ref-type="table-fn" rid="TFN5">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative BUN (mg/dl)</td><td align="center" rowspan="1" colspan="1">16.0 (8.0-35.0)</td><td align="center" rowspan="1" colspan="1">17.0 (9.0-55.0)</td><td align="center" rowspan="1" colspan="1">0.10<xref ref-type="table-fn" rid="TFN5">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative creatinine clearance (ml/min)</td><td align="center" rowspan="1" colspan="1">109 (31-180)</td><td align="center" rowspan="1" colspan="1">111 (63-186)</td><td align="center" rowspan="1" colspan="1">0.96<xref ref-type="table-fn" rid="TFN5">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative fasting blood glucose (mg/dl)</td><td align="center" rowspan="1" colspan="1">94 (62-135)</td><td align="center" rowspan="1" colspan="1">95 (69-136)</td><td align="center" rowspan="1" colspan="1">0.74<xref ref-type="table-fn" rid="TFN5">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative first day hemoglobin (mg/dl)</td><td align="center" rowspan="1" colspan="1">9.1 (7.5-12.0)</td><td align="center" rowspan="1" colspan="1">9.0 (7.4-12.6)</td><td align="center" rowspan="1" colspan="1">0.13<xref ref-type="table-fn" rid="TFN5">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative first day creatinine (mg/L)</td><td align="center" rowspan="1" colspan="1">0.85 (0.50-2.00)</td><td align="center" rowspan="1" colspan="1">1.00 (0.56-2.60)</td><td align="center" rowspan="1" colspan="1">0.01<xref ref-type="table-fn" rid="TFN5">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative third day creatinine (mg/dl)</td><td align="center" rowspan="1" colspan="1">0.79 (0.40-1.70)</td><td align="center" rowspan="1" colspan="1">0.87 (0.50-3.90)</td><td align="center" rowspan="1" colspan="1">0.001<xref ref-type="table-fn" rid="TFN5">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative seventh day creatinine (mg/dl)</td><td align="center" rowspan="1" colspan="1">0.80 (0.50-1.80)</td><td align="center" rowspan="1" colspan="1">0.88 (0.50-2.80)</td><td align="center" rowspan="1" colspan="1">0.001<xref ref-type="table-fn" rid="TFN5">**</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>BUN = blood urea nitrogen.</p></fn><fn id="TFN4"><p>* Pearson Chi-Square test or Fisher's Exact test;</p></fn><fn id="TFN5"><label>**</label><p>Mann-Whitney U test</p></fn></table-wrap-foot></table-wrap><p>Intraoperative and postoperative data of the patients are shown in <xref ref-type="table" rid="t3">Table 3</xref>. ICU length of stay
(<italic>P</italic>=0.004) was significantly different between the groups.</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Intraoperative and postoperative data of the patients.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">HbA1c &#x0003c;5.6 Group 1 (n=112)</th><th align="center" rowspan="1" colspan="1">HbA1c &#x02265;5.6 Group 2 (n=90)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Aortic cross clamp time (minutes) Median (min-max)</td><td align="center" rowspan="1" colspan="1">60 (12-102)</td><td align="center" rowspan="1" colspan="1">57.5 (16-97)</td><td align="center" rowspan="1" colspan="1">0.94<xref ref-type="table-fn" rid="TFN8">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">CPB time (minutes) Median (min-max)</td><td align="center" rowspan="1" colspan="1">95 (30-138)</td><td align="center" rowspan="1" colspan="1">93.5 (37-138)</td><td align="center" rowspan="1" colspan="1">0.75<xref ref-type="table-fn" rid="TFN8">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Use of blood products</td><td align="center" rowspan="1" colspan="1">48 (42.9%)</td><td align="center" rowspan="1" colspan="1">44 (48.9%)</td><td align="center" rowspan="1" colspan="1">0.39<xref ref-type="table-fn" rid="TFN7">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Use of inotropic support</td><td align="center" rowspan="1" colspan="1">20 (17.9%)</td><td align="center" rowspan="1" colspan="1">14 (15.6%)</td><td align="center" rowspan="1" colspan="1">0.66<xref ref-type="table-fn" rid="TFN7">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Amount of drainage (ml) Median (min-max)</td><td align="center" rowspan="1" colspan="1">350 (150-1100)</td><td align="center" rowspan="1" colspan="1">350 (150-1200)</td><td align="center" rowspan="1" colspan="1">0.51<xref ref-type="table-fn" rid="TFN8">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Intubation time (hours) Median (min-max)</td><td align="center" rowspan="1" colspan="1">5 (3-9)</td><td align="center" rowspan="1" colspan="1">5 (3-12)</td><td align="center" rowspan="1" colspan="1">0.74<xref ref-type="table-fn" rid="TFN8">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Intensive care unit stay (hours) Median (min-max)</td><td align="center" rowspan="1" colspan="1">21 (17-46)</td><td align="center" rowspan="1" colspan="1">21.5 (18-67)</td><td align="center" rowspan="1" colspan="1">0.004<xref ref-type="table-fn" rid="TFN8">**</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><p>CPB = cardiopulmonary bypass.</p></fn><fn id="TFN7"><label>*</label><p>Pearson Chi-Square test or Fisher's Exact test;</p></fn><fn id="TFN8"><label>**</label><p>Mann-Whitney U test</p></fn></table-wrap-foot></table-wrap><p>Postoperative AKI occurred in 4 (3.6%) patients in group 1 and in 15 (16.7%) in group
2, showing a statistically significant difference between the groups
(<italic>P</italic>=0.0002). Mortality in the early postoperative period
occurred in 2 (1.8%) patients in group 1 and in 6 (6.7%) in group 2, and there was
no statistically significant difference between the groups
(<italic>P</italic>=0.14). Renal replacement therapy in the early postoperative
period was required in 4 (3.6%) patients in group 1 and in 6 (6.7%) in group 2,
showing no statistically significant difference between the groups
(<italic>P</italic>=0.35).</p><p>Sensitivity and specificity of preoperative HbA<sub>1c</sub> levels to predict AKI in
non-diabetic patients after CABG was 79% and 59%, respectively. Positive predictive
and negative predictive values were 17% and 96%, respectively. Preoperative
HbA<sub>1c</sub> levels higher than 5.6% had an odds ratio of 5.41 for AKI.</p><p>Results of univariate and multivariate regression analyses of preoperative risk
factors that may influence the development of AKI after CABG in non-diabetic
patients are shown in <xref ref-type="table" rid="t4">Table 4</xref>. In univariate
regression analysis, preoperative creatinine (<italic>P</italic>=0.001),
preoperative blood urea nitrogen (BUN) (<italic>P</italic>=0.0001), and preoperative
HbA<sub>1c</sub> (<italic>P</italic>=0.0001) levels were found to be associated
with postoperative AKI occurrence. In multivariate regression analysis,
HbA<sub>1c</sub> (OR 11.17, 95% CI:2.21-56.33, <italic>P</italic>=0.003) was
found to be independently associated with an increased risk for AKI.</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Univariate and multivariate regression analysis of preoperative risk factors
for acute kidney injury.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" colspan="4" rowspan="1">Acute Kidney Injury</th></tr><tr><th align="center" rowspan="2" colspan="1">Variables</th><th align="center" rowspan="2" colspan="1">Unadjusted OR (95% CI)</th><th align="center" rowspan="2" colspan="1"><italic>P</italic></th><th align="center" rowspan="1" colspan="1">Adjusted</th><th align="center" rowspan="2" colspan="1"><italic>P</italic></th></tr><tr><th align="center" rowspan="1" colspan="1">OR (95% CI)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Male gender</td><td align="center" rowspan="1" colspan="1">0.66 (0.22-1.96)</td><td align="center" rowspan="1" colspan="1">0.46</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">1.04 (0.99-1.09)</td><td align="center" rowspan="1" colspan="1">0.16</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Ejection fraction</td><td align="center" rowspan="1" colspan="1">1.04 (0.98-1.11)</td><td align="center" rowspan="1" colspan="1">0.18</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">1.41 (0.51-3.87)</td><td align="center" rowspan="1" colspan="1">0.51</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Hyperlipidaemia</td><td align="center" rowspan="1" colspan="1">1.28 (0.50-3.30)</td><td align="center" rowspan="1" colspan="1">0.61</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking</td><td align="center" rowspan="1" colspan="1">0.62 (0.23-1.71)</td><td align="center" rowspan="1" colspan="1">0.36</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative fasting blood glucose</td><td align="center" rowspan="1" colspan="1">0.98 (0.95-1.01)</td><td align="center" rowspan="1" colspan="1">0.18</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative creatinine</td><td align="center" rowspan="1" colspan="1">49.36 (4.69-519.63)</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">6.21 (0.27-144.64)</td><td align="center" rowspan="1" colspan="1">0.26</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative hemoglobin</td><td align="center" rowspan="1" colspan="1">0.83 (0.60-1.14)</td><td align="center" rowspan="1" colspan="1">0.24</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative BUN</td><td align="center" rowspan="1" colspan="1">1.15 (1.08-1.23)</td><td align="center" rowspan="1" colspan="1">0.0001</td><td align="center" rowspan="1" colspan="1">1.07 (0.98-1.17)</td><td align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative creatinine clearance</td><td align="center" rowspan="1" colspan="1">0.99 (0.97-1.01)</td><td align="center" rowspan="1" colspan="1">0.22</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative HbA1c</td><td align="center" rowspan="1" colspan="1">29.04 (6.49-130.03)</td><td align="center" rowspan="1" colspan="1">0.0001</td><td align="center" rowspan="1" colspan="1">11.17 (2.21-56.33)</td><td align="center" rowspan="1" colspan="1">0.003</td></tr></tbody></table><table-wrap-foot><fn id="TFN9"><p>BUN = blood urea nitrogen; HbA1c = Glycosylated Hemoglobin (Hemoglobin
A<sub>1c</sub>)</p></fn></table-wrap-foot></table-wrap><p>ROC curve analysis of HbA<sub>1c</sub> level, which was found to be a risk factor for
postoperative AKI occurrence in multivariate regression analysis, is depicted in
<xref ref-type="fig" rid="f2">Figure 2</xref>. Cut-off value for
HbA<sub>1c</sub> level was determined as 5.75%, at which sensitivity,
specificity of the test, and AUC (area under curve) were calculated as 73.7%, 65%,
and 0.76 (95% CI=0.62-0.95, <italic>P</italic>=0.0001), respectively.</p><p><fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>ROC curve analysis of preoperative HbA<sub>1c</sub> regarding occurrence
of postoperative AKI. Cut-off value for HbA<sub>1c</sub> level was
determined as 5.75%, at which sensitivity, specificity of the test, and
AUC (area under curve) were calculated as 73.7%, 65.0%, and 0.76 (95%
CI=0.62-0.95, P=0.0001), respectively</p></caption><graphic xlink:href="rbccv-32-02-0083-g02"/></fig></p><sec><title>Study Limitations</title><p>There are some limitations to our study. This study was carried out at a single
center, with a limited number of patients, and it was designed as a
retrospective study rather than a randomized trial.</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>AKI, not rarely seen following cardiac surgery, prolongs ICU and hospital length of
stay and results in increased health costs and mortality rates<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>AKI following cardiac surgery is a multifactorial state. Risk factors are advanced
age, presence of diabetes mellitus, hypertension, low preoperative glomerular
filtration rate (GFR) (&#x0003c;60 ml/min/m<sup>2</sup>), left ventricular systolic
dysfunction (LVEF&#x0003c;35%), preexisting kidney dysfunction, atherosclerosis of the
ascending aorta, urgent or emergent surgery following myocardial infarction or
percutaneous cardiac intervention, and administration of nephrotoxic
agents<sup>[<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r14" ref-type="bibr">14</xref>]</sup>. Intraoperative factors
also contribute to the development of AKI during cardiac surgery, such as renal
hypoperfusion, nonpulsatile flow, and systemic inflammatory response syndrome due to
CPB<sup>[<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref>]</sup>. Demographic data and risk
factors for AKI such as hypertension, low ejection fraction and EuroSCORE values
were similar in both groups.</p><p>Long term survival of patients operated for cardiac surgery is directly proportional
to the severity of AKI, which is related to changes in serum creatinine
levels<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>.
Our results showed that patients with higher preoperative HbA<sub>1c</sub> levels
had higher creatinine levels at 1<sup>st</sup>, 3<sup>rd</sup> and 7<sup>th</sup>
postoperative days. Nevertheless, there was no difference in mortality. Instead,
there was a significant difference when associated with prolonged ICU stay.</p><p>AKI following CPB is an important cause of morbidity and mortality<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>. Postoperative AKI
requiring renal replacement has an independent effect on morbidity and early
mortality. It is reported that the overall mortality due to AKI is
40-80%<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>.
In the recent literature, there are several studies regarding early diagnosis of AKI
and prevention of the inflammation process that is an accepted cause of
AKI<sup>[<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r20" ref-type="bibr">20</xref>]</sup>. In a study by Freeland et
al.<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>, blood
transfusion was found as an independent risk factor for development of AKI following
cardiac surgery. The same study also mentioned that longer aortic cross clamp and
CPB times increased the incidence of AKI following cardiac surgery<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. In a study by Khilji et
al.<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>,
both CPB and total cross-clamp times have been known as potential risk factors for
developing kidney injury. In contrast with the literature, we did not find any
significant differences between patients with AKI and without AKI regarding CPB and
aortic cross clamp times and usage of blood products.</p><p>High mortality and morbidity rates following CABG operations have been reported in
several studies in patients with type 2 diabetes mellitus (DM)<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>. In addition, some studies
have shown that type 2 DM increases postoperative AKI after CABG<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup>. HbA<sub>1c</sub> level is
a parameter used to evaluate long term glycemic control in patients with
DM<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>. The
American Diabetes Association included HbA<sub>1c</sub> level in the criteria for
diagnosing DM<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>.
Normal HbA<sup>1c</sup> levels are accepted as 4-6%. Tekumit et
al.<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>
found that the borderline level of HbA<sub>1c</sub> was 6.1% for patients undergoing
CABG. In their retrospective study, Hudson et al.<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup> reported that preoperative
HbA<sup>1c</sup> levels over 6% were associated with 30-days postoperative
mortality and occurrence of AKI in patients without DM who underwent open cardiac
surgery.</p><p>In our study, patients were grouped according to HbA<sub>1c</sub> levels, with
borderline level being described as 5.6%. Patients with levels higher than 5.6% had
significantly higher incidence of AKI, according to KGIDO classification. Our
results revealed lower levels of HbA<sup>1c</sup> than other studies as a risk
factor for AKI<sup>[<xref rid="r27" ref-type="bibr">27</xref>,<xref rid="r28" ref-type="bibr">28</xref>]</sup>.</p><p>According to the KDIGO 2012 AKI Guideline, cardiac surgery with CPB is a 1B risk
factor<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup>.
Despite the lack of consensus on AKI and HbA<sub>1c</sub> levels in patients with no
known renal disease, HbA<sup>1c</sup> over 7% is defined as a Class 1A risk factor
for patients with chronic renal disease<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup>. The cut-off value for AKI in our group of patients
was 5.75%.</p><p>Azevedo et al.<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup>
observed that, in critical illness, there was a significant correlation between
blood glucose levels and the incidence of AKI. Halkos et al.<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup> found that
HbA<sup>1c</sup> levels greater than 7% were associated with renal failure.
Additionally, Gumus et al.<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup> found that elevated levels of HbA<sup>1c</sup> were
associated with increased renal complications. Likewise, in our study, a
relationship was found between high preoperative creatinine, BUN, HbA<sub>1c</sub>
levels and occurrence of postoperative AKI in our study. It was also observed that
average HbA<sub>1c</sub> level in the preoperative period is a predictor of AKI in
the early postoperative period following CABG.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>AKI following cardiac surgery causes multiple postoperative complications and leads
to prolonged hospitalization, increased costs, and eventually increased mortality
rates. Our results suggest that elevated preoperative HbA<sub>1c</sub> level is
associated with postoperative AKI and prolonged ICU stay in non-diabetic patients
undergoing CABG. However, further prospective randomized studies are warranted to
confirm these results.</p><table-wrap id="t6" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">CUK</td><td align="left" rowspan="1" colspan="1">Conception and study design; execution of operations;
<break/>analysis and/or data interpretation; statistical analysis;
<break/>manuscript writing or critical review of its content; final
<break/>manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ATK</td><td align="left" rowspan="1" colspan="1">Conception and study design; execution of operations;
<break/>analysis and/or data interpretation; statistical analysis;
<break/>manuscript writing or critical review of its content; final
<break/>manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RA</td><td align="left" rowspan="1" colspan="1">Conception and study design; execution of operations;
<break/>analysis and/or data interpretation; statistical analysis;
<break/>manuscript writing or critical review of its content; final
<break/>manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD</td><td align="left" rowspan="1" colspan="1">Conception and study design; execution of operations;
<break/>analysis and/or data interpretation; statistical analysis;
<break/>manuscript writing or critical review of its content; final
<break/>manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HP</td><td align="left" rowspan="1" colspan="1">Conception and study design; execution of operations;
<break/>analysis and/or data interpretation; statistical analysis;
<break/>manuscript writing or critical review of its content; final
<break/>manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HS</td><td align="left" rowspan="1" colspan="1">Conception and study design; execution of operations;
<break/>analysis and/or data interpretation; statistical analysis;
<break/>manuscript writing or critical review of its content; final
<break/>manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">OF</td><td align="left" rowspan="1" colspan="1">Conception and study design; execution of operations;
<break/>analysis and/or data interpretation; statistical analysis;
<break/>manuscript writing or critical review of its content; final
<break/>manuscript approval</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at the Siyami Ersek Training and Research Hospital,
Istanbul, Turkey.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beyazpinar</surname><given-names>DZ</given-names></name><name><surname>G&#x000fc;ltekin</surname><given-names>B</given-names></name><name><surname>Kayipmaz</surname><given-names>AE</given-names></name><name><surname>Kayipmaz</surname><given-names>&#x000c7;</given-names></name><name><surname>Sezgin</surname><given-names>A</given-names></name><name><surname>Giray</surname><given-names>TA</given-names></name><etal/></person-group><article-title>A comparison of two coronary artery bypass graft surgery
techniques with respect to acute kidney injury</article-title><source>Turk Gogus Kalp Dama</source><year>2015</year><volume>23</volume><issue>4</issue><fpage>643</fpage><lpage>650</lpage></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricci</surname><given-names>Z</given-names></name><name><surname>Di Nardo</surname><given-names>M</given-names></name><name><surname>Iacoella</surname><given-names>C</given-names></name><name><surname>Netto</surname><given-names>R</given-names></name><name><surname>Picca</surname><given-names>S</given-names></name><name><surname>Cogo</surname><given-names>P</given-names></name></person-group><article-title>Pediatric RIFLE for acute kidney injury diagnosis and prognosis
for children undergoing cardiac surgery: a single-center prospective
observational study</article-title><source>Pediatr Cardiol</source><year>2013</year><volume>34</volume><issue>6</issue><fpage>1404</fpage><lpage>1408</lpage><pub-id pub-id-type="pmid">23430323</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kochi</surname><given-names>AC</given-names></name><name><surname>Martins</surname><given-names>AS</given-names></name><name><surname>Balbi</surname><given-names>AL</given-names></name><name><surname>Silva</surname><given-names>MAM</given-names></name><name><surname>Lima</surname><given-names>MCP</given-names></name><name><surname>Martin</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Preoperative risk factors for the development of acute renal
failure in cardiac surgery</article-title><source>Braz J Cardiovasc Surg</source><year>2007</year><volume>22</volume><issue>1</issue><fpage>33</fpage><lpage>40</lpage></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>AJ</given-names></name><name><surname>Evora</surname><given-names>PRB</given-names></name><name><surname>Bassetto</surname><given-names>S</given-names></name><name><surname>Alves J&#x000fa;nior</surname><given-names>L</given-names></name><name><surname>Scorzoni Filho</surname><given-names>A</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>WF</given-names></name><etal/></person-group><article-title>Risk factors for acute kidney injury after cardiac
surgery</article-title><source>Braz J Cardiovasc Surg</source><year>2009</year><volume>24</volume><issue>4</issue><fpage>441</fpage><lpage>446</lpage></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takaki</surname><given-names>S</given-names></name><name><surname>Shehabi</surname><given-names>Y</given-names></name><name><surname>Pickering</surname><given-names>JW</given-names></name><name><surname>Endre</surname><given-names>Z</given-names></name><name><surname>Miyashita</surname><given-names>T</given-names></name><name><surname>Goto</surname><given-names>T</given-names></name></person-group><article-title>Perioperative change in creatinine following cardiac surgery with
cardiopulmonary bypass is useful in predicting acute kidney injury: a
single-centre retrospective cohort study</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2015</year><volume>21</volume><issue>4</issue><fpage>465</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">26160965</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeland</surname><given-names>K</given-names></name><name><surname>Hamidian Jahromi</surname><given-names>A</given-names></name><name><surname>Duvall</surname><given-names>LM</given-names></name><name><surname>Mancini</surname><given-names>MC</given-names></name></person-group><article-title>Postoperative blood transfusion is an independent predictor of
acute kidney injury in cardiac surgery patients</article-title><source>J Nephropathol</source><year>2015</year><volume>4</volume><issue>4</issue><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">26457259</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>F</given-names></name><name><surname>Doi</surname><given-names>Y</given-names></name><name><surname>Ninomiya</surname><given-names>T</given-names></name><name><surname>Hirakawa</surname><given-names>Y</given-names></name><name><surname>Mukai</surname><given-names>N</given-names></name><name><surname>Hata</surname><given-names>J</given-names></name><etal/></person-group><article-title>Haemoglobin A1c even within non-diabetic level is a predictor of
cardiovascular disease in a general Japanese population: the Hisayama
Study</article-title><source>Cardiovasc Diabetol</source><year>2013</year><volume>12</volume><fpage>164</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">24195452</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faritous</surname><given-names>Z</given-names></name><name><surname>Ardeshiri</surname><given-names>M</given-names></name><name><surname>Yazdanian</surname><given-names>F</given-names></name><name><surname>Jalali</surname><given-names>A</given-names></name><name><surname>Totonchi</surname><given-names>Z</given-names></name><name><surname>Azarfarin</surname><given-names>R</given-names></name></person-group><article-title>Hyperglycemia or high hemoglobin A1c: which one is more
associated with morbidity and mortality after coronary artery bypass graft
surgery?</article-title><source>Ann Thorac Cardiovasc Surg</source><year>2014</year><volume>20</volume><issue>3</issue><fpage>223</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">23666248</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gumus</surname><given-names>F</given-names></name><name><surname>Polat</surname><given-names>A</given-names></name><name><surname>Sinikoglu</surname><given-names>SN</given-names></name><name><surname>Yektas</surname><given-names>A</given-names></name><name><surname>Erkalp</surname><given-names>K</given-names></name><name><surname>Alagol</surname><given-names>A</given-names></name></person-group><article-title>Use of a lower cut-off value for HbA1c to predict postoperative
renal complication risk in patients undergoing coronary artery bypass
grafting</article-title><source>J Cardiothorac Vasc Anesth</source><year>2013</year><volume>27</volume><issue>6</issue><fpage>1167</fpage><lpage>1173</lpage><pub-id pub-id-type="pmid">24008164</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okusa</surname><given-names>MD</given-names></name><name><surname>Davenport</surname><given-names>A</given-names></name></person-group><article-title>Reading between the (guide)lines: the KDIGO practice guideline on
acute kidney injury in the individual patient</article-title><source>Kidney Int</source><year>2014</year><volume>85</volume><issue>1</issue><fpage>39</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">24067436</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lassnigg</surname><given-names>A</given-names></name><name><surname>Donner</surname><given-names>E</given-names></name><name><surname>Grubhofer</surname><given-names>G</given-names></name><name><surname>Presterl</surname><given-names>E</given-names></name><name><surname>Druml</surname><given-names>W</given-names></name><name><surname>Hiesmayr</surname><given-names>M</given-names></name></person-group><article-title>Lack of renoprotective effects of dopamine and furosemide during
cardiac surgery</article-title><source>J Am Soc Nephrol</source><year>2000</year><volume>11</volume><issue>1</issue><fpage>97</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">10616845</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cockcroft</surname><given-names>DW</given-names></name><name><surname>Gault</surname><given-names>MH</given-names></name></person-group><article-title>Prediction of creatinine clearance from serum
creatinine</article-title><source>Nephron</source><year>1976</year><volume>16</volume><issue>1</issue><fpage>31</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">1244564</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maitra</surname><given-names>G</given-names></name><name><surname>Ahmed</surname><given-names>A</given-names></name><name><surname>Rudra</surname><given-names>A</given-names></name><name><surname>Wankhede</surname><given-names>R</given-names></name><name><surname>Sengupta</surname><given-names>S</given-names></name><name><surname>Das</surname><given-names>T</given-names></name></person-group><article-title>Renal dysfunction after off-pump coronary artery bypass surgery:
risk factors and preventive strategies</article-title><source>Indian J Anaesth</source><year>2009</year><volume>53</volume><issue>4</issue><fpage>401</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">20640201</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doddakula</surname><given-names>K</given-names></name><name><surname>Al-Sarraf</surname><given-names>N</given-names></name><name><surname>Gately</surname><given-names>K</given-names></name><name><surname>Hughes</surname><given-names>A</given-names></name><name><surname>Tolan</surname><given-names>M</given-names></name><name><surname>Young</surname><given-names>V</given-names></name><etal/></person-group><article-title>Predictors of acute renal failure requiring renal replacement
therapy post cardiac surgery in patients with preoperatively normal renal
function</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2007</year><volume>6</volume><issue>3</issue><fpage>314</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">17669854</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suen</surname><given-names>WS</given-names></name><name><surname>Mok</surname><given-names>CK</given-names></name><name><surname>Chiu</surname><given-names>SW</given-names></name><name><surname>Cheung</surname><given-names>KL</given-names></name><name><surname>Lee</surname><given-names>WT</given-names></name><name><surname>Cheung</surname><given-names>D</given-names></name><etal/></person-group><article-title>Risk factors for development of acute renal failure (ARF)
requiring dialysis in patients undergoing cardiac surgery</article-title><source>Angiology</source><year>1998</year><volume>49</volume><issue>10</issue><fpage>789</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">9783643</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isbir</surname><given-names>SC</given-names></name><name><surname>Tekeli</surname><given-names>A</given-names></name><name><surname>Ergen</surname><given-names>A</given-names></name><name><surname>Yilmaz</surname><given-names>H</given-names></name><name><surname>Ak</surname><given-names>K</given-names></name><name><surname>Civelek</surname><given-names>A</given-names></name><etal/></person-group><article-title>Genetic polymorphisms contribute to acute kidney injury after
coronary artery bypass grafting</article-title><source>Heart Surg Forum</source><year>2007</year><volume>10</volume><issue>6</issue><fpage>E439</fpage><lpage>E444</lpage><pub-id pub-id-type="pmid">17921131</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobson</surname><given-names>CE</given-names></name><name><surname>Yavas</surname><given-names>S</given-names></name><name><surname>Segal</surname><given-names>MS</given-names></name><name><surname>Schold</surname><given-names>JD</given-names></name><name><surname>Tribble</surname><given-names>CG</given-names></name><name><surname>Layon</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Acute kidney injury is associated with increased long-term
mortality after cardiothoracic surgery</article-title><source>Circulation</source><year>2009</year><volume>119</volume><issue>18</issue><fpage>2444</fpage><lpage>2453</lpage><pub-id pub-id-type="pmid">19398670</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname><given-names>DN</given-names></name><name><surname>Ronco</surname><given-names>C</given-names></name><name><surname>Katz</surname><given-names>N</given-names></name></person-group><article-title>Neutrophil gelatinase-associated lipocalin: a promising biomarker
for detecting cardiac surgery-associated acute kidney injury</article-title><source>J Thorac Cardiovasc Surg</source><year>2010</year><volume>139</volume><issue>5</issue><fpage>1101</fpage><lpage>1106</lpage><pub-id pub-id-type="pmid">20412947</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arun</surname><given-names>O</given-names></name><name><surname>&#x000c7;elik</surname><given-names>G</given-names></name><name><surname>Oc</surname><given-names>B</given-names></name><name><surname>Unlu</surname><given-names>A</given-names></name><name><surname>Celik</surname><given-names>JB</given-names></name><name><surname>Oc</surname><given-names>M</given-names></name><etal/></person-group><article-title>NGAL and cystatin C as early biomarkers for prediction of acute
kidney injury in diabetic and non-diabetic patients undergoing coronary
artery bypass graft surgery. Presented at the 63rd International Congress of
the European Society for Cardiovascular and Endovascular Surgery 2014 Apr
24-27; Nice, France.</article-title><source>J Cardiovasc Surg</source><year>2014</year><volume>55</volume><issue>Suppl 2</issue><issue>2</issue><size units="pages">79</size></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loef</surname><given-names>BG</given-names></name><name><surname>Henning</surname><given-names>RH</given-names></name><name><surname>Epema</surname><given-names>AH</given-names></name><name><surname>Rietman</surname><given-names>GW</given-names></name><name><surname>van Oeveren</surname><given-names>W</given-names></name><name><surname>Navis</surname><given-names>GJ</given-names></name><etal/></person-group><article-title>Effect of dexamethasone on perioperative renal function
impairment during cardiac surgery with cardiopulmonary
bypass</article-title><source>Br J Anaesth</source><year>2004</year><volume>93</volume><issue>6</issue><fpage>793</fpage><lpage>798</lpage><pub-id pub-id-type="pmid">15377582</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khilji</surname><given-names>SA</given-names></name><name><surname>Khan</surname><given-names>AH</given-names></name></person-group><article-title>Acute renal failure after cardiopulmonary bypass
surgery</article-title><source>J Ayub Med Coll Abbottabad</source><year>2004</year><volume>16</volume><fpage>25</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">15631366</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>Y</given-names></name><name><surname>Raz</surname><given-names>I</given-names></name><name><surname>Merin</surname><given-names>G</given-names></name><name><surname>Mozes</surname><given-names>B</given-names></name></person-group><article-title>Comparison of factors associated with 30-day mortality after
coronary artery bypass grafting in patients with versus without diabetes
mellitus. Israeli Coronary Artery Bypass (ISCAB) Study
Consortium</article-title><source>Am J Cardiol</source><year>1998</year><volume>81</volume><issue>1</issue><fpage>7</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">9462597</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubal</surname><given-names>C</given-names></name><name><surname>Srinivasan</surname><given-names>AK</given-names></name><name><surname>Grayson</surname><given-names>AD</given-names></name><name><surname>Fabri</surname><given-names>BM</given-names></name><name><surname>Chalmers</surname><given-names>JA</given-names></name></person-group><article-title>Effect of risk-adjusted diabetes on mortality and morbidity after
coronary artery bypass surgery</article-title><source>Ann Thorac Surg</source><year>2005</year><volume>79</volume><issue>5</issue><fpage>1570</fpage><lpage>1576</lpage><pub-id pub-id-type="pmid">15854935</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Diabetes Association</collab></person-group><article-title>Standards of medical care in diabetes</article-title><source>Diabetes Care</source><year>2005</year><volume>28</volume><fpage>4</fpage><lpage>36</lpage></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tekumit</surname><given-names>H</given-names></name><name><surname>Cenal</surname><given-names>AR</given-names></name><name><surname>Polat</surname><given-names>A</given-names></name><name><surname>Uzun</surname><given-names>K</given-names></name><name><surname>Tataroglu</surname><given-names>C</given-names></name><name><surname>Akinci</surname><given-names>E</given-names></name></person-group><article-title>Diagnostic value of hemoglobin A1c and fasting plasma glucose
levels in coronary artery bypass grafting patients with undiagnosed diabetes
mellitus</article-title><source>Ann Thorac Surg</source><year>2010</year><volume>89</volume><issue>5</issue><fpage>1482</fpage><lpage>1487</lpage><pub-id pub-id-type="pmid">20417764</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>CC</given-names></name><name><surname>Welsby</surname><given-names>IJ</given-names></name><name><surname>Phillips-Bute</surname><given-names>B</given-names></name><name><surname>Mathew</surname><given-names>JP</given-names></name><name><surname>Lutz</surname><given-names>A</given-names></name><name><surname>Chad Huges</surname><given-names>G</given-names></name><etal/></person-group><article-title>Glycosylated hemoglobin levels and outcome in non-diabetic
cardiac surgery patients</article-title><source>Can J Anesth</source><year>2010</year><volume>57</volume><issue>6</issue><fpage>565</fpage><lpage>572</lpage><pub-id pub-id-type="pmid">20221858</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><article-title>KDIGO clinical practice guideline for acute kidney
injury</article-title><source>Kidney Int Suppl</source><year>2012</year><volume>2</volume><issue>1</issue><fpage>1</fpage><lpage>138</lpage></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><article-title>KDIGO 2012 clinical practice guideline for the evaluation and
management of chronic kidney disease</article-title><source>Kidney Int Suppl</source><year>2013</year><volume>3</volume><issue>1</issue><fpage>1</fpage><lpage>150</lpage></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azevedo</surname><given-names>JRA</given-names></name><name><surname>Azevedo</surname><given-names>RP</given-names></name><name><surname>Lucena</surname><given-names>LC</given-names></name><name><surname>Costa</surname><given-names>NNR</given-names></name><name><surname>Silva</surname><given-names>WS</given-names></name></person-group><article-title>Impact of glycemic control on the incidence of acute kidney
injury in critically ill patients: a comparison of two strategies using the
RIFLE criteria</article-title><source>Clinics (Sao Paulo)</source><year>2010</year><volume>65</volume><issue>8</issue><fpage>769</fpage><lpage>773</lpage><pub-id pub-id-type="pmid">20835553</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halkos</surname><given-names>ME</given-names></name><name><surname>Puskas</surname><given-names>JD</given-names></name><name><surname>Lattouf</surname><given-names>OM</given-names></name><name><surname>Kilgo</surname><given-names>P</given-names></name><name><surname>Kerendi</surname><given-names>F</given-names></name><name><surname>Song</surname><given-names>HK</given-names></name><etal/></person-group><article-title>Elevated preoperative hemoglobin A1c level is predictive of
adverse events after coronary artery bypass surgery</article-title><source>J Thorac Cardiovasc Surg</source><year>2008</year><volume>136</volume><issue>3</issue><fpage>631</fpage><lpage>640</lpage><pub-id pub-id-type="pmid">18805264</pub-id></element-citation></ref></ref-list></back></article>